Home» Circulars» An Investment Mission To Fiji From 16 19 May 2023 Back
 
An Investment Mission to Fiji from 16-19 May 2023
 

 

PxlNwLtrHeaderLogo


PXL/HO/Cir-008/2023-24                                                                            Date: 18.04.2023

Hyderabad

 

Hyderabad

 

Dear Sir/Madam,

 

Subject: An Investment Mission to Fiji from 16-19 May 2023

 

Members are aware that Pharmexcil has been facilitating valuable information to Indian Exporters in close coordination with our missions abroad and promoting Indian pharmaceuticals worldwide. Pharmexcil is further in receipt of communication from High Commission of the Republic of Fiji in New Delhi regarding Investment & Export Opportunities in Fiji.

 

The High Commission of the Republic of Fiji in New Delhi is organizing an Investment Mission programme to Fiji from 16-19 May 2023. The mission has planned to coincide with the hosting of the International Girmit Conference scheduled from 12-13 May and the Girmit Day Celebrations in Suva, Fiji is on 15th May 2023.

 

This will be a unique opportunity for our Indian Pharma Industry to participate in the conference and attend the Girmit celebrations as Special Guests. It will also be a unique opportunity to meet the relevant Government and statutory bodies and the business community for further collaboration and to build future networks. There will be abundant opportunities for bilateral meetings and to register new businesses if required.

 

For further information, members can directly connect with the mission on tel. no. +91-11-46564574 or email at tradeinvestmentfiji@gmail.comor visit them at the High Commission of the Republic of Fiji at 2/27, Shanti Niketan, New Delhi 10021 to discuss their business plans and requirements.

 

Further contact details of the missions are as follows:

Mr. Elia Sevutia, Second Secretary - +91-9971584275 and Ms Paulina George, Executive Assistant to the High Commissioner - +91-9810762325.

 

Member companies who are interested may take advantage of this and explore the opportunities in these sectors to enhance India’s Pharma exports.

 

With regards

 

 

Uday Bhaskar

Director General